| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |